RxDoctor Payments Data

Kathleen Ciarletta

Family · Bayville, NYNPI 1750024824

Payments from drug & device makers

$3,921in general payments, 2019–2025

Across 149 payments — averaging $26.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • MML US, Inc.$1K
  • Nevro Corp.$483
  • Scilex Pharmaceuticals Inc.$373
  • Relievant Medsystems, Inc.$272
  • Kowa Pharmaceuticals America, Inc.$254
  • AbbVie$179
  • plus $1K from 17 others

What the payments were for

  • Food & beverage$3,921100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,921 in reported general payments places this provider in the 90th percentile of 8,883 family providers in New York.

See all family providers in New York

Most prescribed under Part D

DrugClaimsCost to plans & patients
OxycontinOxycodone Hcl72$74,523
PercocetOxycodone Hcl/Acetaminophen13$63,185
RelistorMethylnaltrexone Bromide21$48,474
ZtlidoLidocaine57$44,894
Diclofenac Sodium112$37,081
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen433$33,734
Xtampza ErOxycodone Myristate46$23,763
Nucynta ErTapentadol Hcl17$18,783
MovantikNaloxegol Oxalate34$13,307
Naloxone Hcl190$12,569
Oxycodone Hcl528$11,707
Lidocaine86$8,111
Pregabalin195$6,238
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen248$5,367
Gabapentin404$4,500

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor$125$48,47421 claims
Scilex Pharmaceuticals Inc.Ztlido$373$44,89457 claims
Collegium Pharmaceutical, Inc.Xtampza Er, Nucynta Er$70$42,54663 claims
Hikma Pharmaceuticals USABuprenorphine, Buprenorphine-Naloxone, Morphine Sulfate, Buprenorphine Hcl$18$10,18573 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 8,883 family providers in New York.

Other family in Bayville

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →